Medicamen Biotech Ltd. — Director's Dealing 2021

Dec 10, 2021

MEDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)

Tel.: 011 - 47589500-51 (50 Lines). E-mail: info@medicamen.com Web: www.medicamen.com CIN No.: L74899DL1993PLC056594

Dated: 10.12.2021

To. BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001

National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

Scrip Code: 531146

Subject: Intimation as per Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam,

Please find attached disclosure dated December 09, 2021 in Form-C pursuant to Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Growel Remedies Limited for sale of 14,025 Equity Shares from the open market.

We request you to treat this intimation as compliance with Regulation $7(2)$ (b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and take the same on record.

For Medicamen Biotech Limited NICe $\sigma$

Parul ChoudHary^* Company Secretary ACS: 44157

Encl: $A/a$

Dated: 09.12.2021

To, The Compliance Officer Medicamen Biotech Limited 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, 110019

Subject: Submission of disclosure under Regulation $7(2)(a)$ read with regulation $6(2)$ of SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam,

With reference to the above captioned subject, we would like to apprise you that Growel Remedies Limited (Promoter of Medicamen Biotech Limited ("Target Company")) has sold 14,025 Equity Shares of Rs. 10/- each through the open market.

In this connection please find enclosed the required disclosure.

You are requested to take the above information on your records and inform the exchange accordingly.

For Growel Remedies Limited

R. Buhme

Rahul Bishnoi Director DIN: 00317960

Encl: A/a

SEBI (Prohibition of Insider Trading) Regulations, 2015
[Regulation 7 (2) read with Regulation 6(2) – Continual disclosure] FORM C

Name of the company: Medicamen Biotech Limited
ISIN of the company: INE646B01010

Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other
such persons as mentioned in Regul

market/public disposal (on acquisition preferential Mode of rights/	market/ Inter- offer / off transfer, ESOP s etc.) Se	On Market Ø
intimation company Date of $\mathbf{c}$		$\frac{1}{c}$
	$\Gamma$ o	09.12.2021 09.12.2021
disposal of shares Date of allotment acquisition of advice/ shares/ specify	From	07.12.2021
acquisition/disposal Securities held post	shareholding No. and % $\sigma$	equity shares 3,58,019 $(2.93\%)$
	Debenture Rights Convertib Warrants, (For eg- entitleme Type of security Shares, nt, etc.) $\overline{e}$ $\infty$	Equity Shares
Securities aequired/Disposed	(Purchase Invocatio Revocati Transact specify) Others- Pledge please Type /sale ion # ¥	Sale
	Value (In Rs.)	Seven and Fifty Five Eight Hundred Sixty Three Lakhs Ninety Rupees One Crore Rs. 1,03,94,867.55 Four Thousand Paisa only/-)
	Σò.	14,025 Equity Shares
	(For eg. Converti Type of security Warrant Debentu etc.)etc.) res Rights entitlem Shares, ents ble S,	Equity Shares
	sharehold and % Νo. ins of	3,72,044 $(3.05\%)$ equity shares
aequisition/disposal Securities held prior to	entitlements Convertible Debentures Warrants, - Shares, Type of security (For eg. Rights etc.)	Equity shares
of Category of group/desig (Promoter/ promoter member Person nated the	s/immediate to/others Director relative person/ etc.)	Promoter (group)
& address CIN/DIN contact Name, PAN, with nos.		Growel Wellness Innovations Ltd.) Tower, 43, Nehru $\frac{\text{Constant}}{\text{+}919810739079}$ Address: 1506, Vame: Growel AABCG3108P Place, New Delhi-110019 Remedies formerly Chiranjiv imited PAN:

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

j $\vdots$

$\begin{array}{cccccccccc} 1 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 &$

Exchange on which the trade was executed					NA
Trading in derivatives (Specify type of contract, Futures or Options etc)	Sell	Number of units	$\stackrel{\triangle}{\scriptstyle\sim}$
		Notional Value			NA
	Buy	Number of units	(contracts * lot	size)	$\stackrel{\triangle}{\scriptstyle\sim}$
			Notional Value		$\stackrel{\triangle}{\scriptstyle\sim}$
		Contract	specifications		$\stackrel{\triangle}{\scriptstyle\sim}$
		Type of	contract		Ž	$\tilde{\phantom{0}}$ $N_{\text{rel}}$

Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options.

Yours faithfully

For Growel Remedies Ltd

$\widehat{\lim }$ R. But ç

Rahul Bishnoi
Director
DIN: 00317960

Date: 09.12.2021
Place: New Delhi

******